Biomea Fusion, Inc. Operating Expenses
Biomea Fusion, Inc. (BMEA) reported Operating Expenses of $12.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- Biomea Fusion, Inc. operating expenses for the quarter ending 2026-06-30 was $12.77M, a 40.00% decline year-over-year.
- Biomea Fusion, Inc. operating expenses for the quarter ending 2026-03-31 was $12.77M, a 57.01% decline year-over-year.
- Biomea Fusion, Inc. operating expenses for the quarter ending 2025-12-31 was $11.72M, a 61.03% decline year-over-year.
- Biomea Fusion, Inc. operating expenses for the quarter ending 2025-09-30 was $20.80M, a 38.88% decline year-over-year.
- Biomea Fusion, Inc. operating expenses for fiscal 2025 was $83.51M, a 42.03% decline from fiscal 2024.
- Biomea Fusion, Inc. operating expenses for fiscal 2024 was $144.07M, a 14.22% increase from fiscal 2023.
- Biomea Fusion, Inc. operating expenses for fiscal 2023 was $126.14M, a 50.82% increase from fiscal 2022.
- Biomea Fusion, Inc. operating expenses for fiscal 2022 was $83.63M, a 100.72% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.77M 10-Q · filed 2026-08-05 | $25.54M 10-Q · filed 2026-08-05 | $37.26M derived: sum of 3 quarters · filed 2026-08-05 | $58.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $12.77M 10-Q · filed 2026-05-11 | $24.49M derived: sum of 2 quarters · filed 2026-05-11 | $45.30M derived: sum of 3 quarters · filed 2026-05-11 | $66.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $32.52M derived: sum of 2 quarters · filed 2026-03-24 | $53.80M derived: sum of 3 quarters · filed 2026-08-05 | $83.51M 10-K · filed 2026-03-24 |
| 2025-09-30 | $20.80M 10-Q · filed 2025-11-04 | $42.08M derived: sum of 2 quarters · filed 2026-08-05 | $71.79M 10-Q · filed 2025-11-04 | $101.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $21.28M 10-Q · filed 2026-08-05 | $50.99M 10-Q · filed 2026-08-05 | $81.06M derived: sum of 3 quarters · filed 2026-08-05 | $115.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $29.71M 10-Q · filed 2026-05-11 | $59.79M derived: sum of 2 quarters · filed 2026-05-11 | $93.83M derived: sum of 3 quarters · filed 2026-05-11 | $132.72M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $30.07M 10-K · filed 2025-03-31 | $64.11M derived: sum of 2 quarters · filed 2025-11-04 | $103.01M derived: sum of 3 quarters · filed 2025-11-04 | $144.07M 10-K · filed 2026-03-24 |
| 2024-09-30 | $34.04M 10-Q · filed 2025-11-04 | $72.94M derived: sum of 2 quarters · filed 2025-11-04 | $114.00M 10-Q · filed 2025-11-04 | $151.32M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $38.90M 10-Q · filed 2025-08-05 | $79.96M 10-Q · filed 2025-08-05 | $117.28M derived: sum of 3 quarters · filed 2025-08-05 | $148.40M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $41.06M 10-Q · filed 2025-05-05 | $78.39M derived: sum of 2 quarters · filed 2025-05-05 | $109.51M derived: sum of 3 quarters · filed 2025-05-05 | $137.16M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $37.33M 10-K · filed 2025-03-31 | $68.45M derived: sum of 2 quarters · filed 2025-03-31 | $96.10M derived: sum of 3 quarters · filed 2025-03-31 | $126.14M 10-K · filed 2026-03-24 |
| 2023-09-30 | $31.12M 10-K · filed 2025-03-31 | $58.78M derived: sum of 2 quarters · filed 2025-03-31 | $88.81M 10-Q · filed 2024-10-29 | $115.08M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $27.66M 10-K · filed 2025-03-31 | $57.69M 10-Q · filed 2024-07-31 | $83.96M derived: sum of 3 quarters · filed 2025-03-31 | $107.45M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $30.03M 10-K · filed 2025-03-31 | $56.31M derived: sum of 2 quarters · filed 2025-03-31 | $79.79M derived: sum of 3 quarters · filed 2025-03-31 | $97.27M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $26.28M 10-K · filed 2024-03-28 | $49.76M derived: sum of 2 quarters · filed 2024-03-28 | $67.23M derived: sum of 3 quarters · filed 2024-03-28 | $83.63M 10-K · filed 2025-03-31 |
| 2022-09-30 | $23.48M 10-K · filed 2024-03-28 | $40.96M derived: sum of 2 quarters · filed 2024-03-28 | $57.36M 10-Q · filed 2023-10-30 | $72.09M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $17.47M 10-K · filed 2024-03-28 | $33.87M 10-Q · filed 2023-07-31 | $48.61M derived: sum of 3 quarters · filed 2024-03-28 | $61.25M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $16.40M 10-K · filed 2024-03-28 | $31.14M derived: sum of 2 quarters · filed 2024-03-28 | $43.77M derived: sum of 3 quarters · filed 2024-03-28 | $52.21M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $14.74M 10-K · filed 2023-03-28 | $27.38M derived: sum of 2 quarters · filed 2023-03-28 | $35.81M derived: sum of 3 quarters · filed 2023-03-28 | $41.67M 10-K · filed 2024-03-28 |
| 2021-09-30 | $12.64M 10-K · filed 2023-03-28 | $21.07M derived: sum of 2 quarters · filed 2023-03-28 | $26.93M 10-Q · filed 2022-11-07 | $30.43M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $8.44M 10-K · filed 2023-03-28 | $14.29M 10-Q · filed 2022-08-01 | $17.79M derived: sum of 3 quarters · filed 2023-03-28 | $18.93M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $5.86M 10-K · filed 2023-03-28 | $9.36M derived: sum of 2 quarters · filed 2023-03-28 | $10.49M derived: sum of 3 quarters · filed 2023-03-28 | $10.79M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $3.50M 10-K · filed 2022-02-28 | $4.63M derived: sum of 2 quarters · filed 2022-02-28 | $4.93M derived: sum of 3 quarters · filed 2022-02-28 | $5.33M 10-K · filed 2023-03-28 |
| 2020-09-30 | $1.14M 10-K · filed 2022-02-28 | $1.43M derived: sum of 2 quarters · filed 2022-02-28 | $1.83M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $295.00K 10-K · filed 2022-02-28 | $693.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $398.00K 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $1.20M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |